SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (1119)4/27/1998 7:35:00 PM
From: scaram(o)uche  Read Replies (1) of 2742
 
>> I spoke with Hal Smith, CIST's PR person, this morning. He stated that Cistron is now
actively involved in cancer vaccine research, and that this work involves "an outside
party." This is good news and is a natural follow-on to the reacquisition of the GTI
(Sandoz/Novartis) sub-license for this research. Hopefully, news of a collaboration will
be forthcoming.

Interestingly, today's (4/27) BioCentury has a lead article on cancer vaccine research. A
number of companies/approaches are discussed. Clearly some of these approaches - as
you've outlined previously - are relevant to CIST. This is a great 'primer.' I recommend
that anyone interested go to the BioCentury website biocentury.com and
request a copy.

Hal also mentioned that CIST's flu vaccine work with Novavax and their wound healing
work are proceeding. Also, Galton and BlueStone are working closely and are in active
discussions with a number of companies. <<

Thanks, Rudy. All good news. However, it all could have been done 16 months ago, when the rationale was set, engraved(*), under Brucie's nose. Would you prefer to see "collaborations" or would you rather see IL-1 bundled with the cash and sold out from under his "management"?

Hal has been polite and professional.

*engraved......

Dear Brucie: Here's a good business plan. Love and smooches, Ricky
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News